v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,178 $ 259
Short-term investments 0 4,304
Accounts receivable and other receivables, net of allowance for credit loss of $559 as of June 30, 2026 and December 31, 2025 559 425
Inventories 930 1,212
Prepaid expenses and other current assets 72 156
Total current assets 5,739 6,356
Property and equipment, net 0 8
Intangible assets, net 39 39
Other noncurrent assets 115 143
Total assets 5,893 6,546
Current liabilities:    
Accounts payable and accrued expenses 1,383 1,789
Total current liabilities 1,646 2,059
Common stock warrant and option liabilities 3,614 347
Total liabilities 5,260 2,406
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.001 par value - 150,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 2,181,715 and 1,373,120 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 66 65
Additional paid-in capital 292,435 285,292
Accumulated deficit (291,868) (281,217)
Total stockholders' equity 633 4,140
Total liabilities and stockholders’ equity 5,893 6,546
Nonrelated Party [Member]    
Current liabilities:    
Other current liabilities $ 263 $ 270